Valuation: Becton, Dickinson and Company

Market Cap 42.68B 37.31B 34.42B 31.64B 59.95B 4,106B 60.98B 411B 161B 2,007B 160B 157B 6,918B P/E 2026 *
38.6x
P/E 2027 * 29.8x
Enterprise Value 59.19B 51.75B 47.74B 43.88B 83.15B 5,695B 84.57B 570B 224B 2,784B 222B 217B 9,595B EV / Sales 2026 *
3.08x
EV / Sales 2027 * 2.87x
Free-Float
74.04%
Yield 2026 *
2.49%
Yield 2027 * 2.53%
1 day+2.81%
1 week+2.87%
Current month+2.35%
1 month+6.43%
3 months-0.41%
6 months-25.66%
Current year-20.19%
1 week 148.34
Extreme 148.34
156.87
1 month 140.11
Extreme 140.11
159.49
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
07-02Tax

Executive/Senior Manager

-1,935 0.0007%
06-26Sell

Executive/Senior Manager

-75 0.0000%
06-24Sell

Executive/Senior Manager

-1,100 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+2.81%+2.87%-13.14%-40.29% 42.68B
+0.35%-6.21%-32.11%-17.29% 155B
+1.48%-1.88%-9.81%-8.19% 103B
-1.89%-4.20%+0.65%+54.93% 57.7B
-1.11%+1.09%+37.83%+53.63% 52.27B
+2.02%-2.13% - - 33.35B
-1.88%-1.80%-14.21%-47.04% 28.06B
+0.38%+1.50%+62.41%-6.78% 25.36B
-0.37%+4.84%-3.11%-17.81% 21.03B
+1.31%+0.94%-7.59%-7.69% 20.61B
Average +0.30%+0.30%+2.32%-4.06% 53.96B
Weighted average by Cap. +0.36%-1.61%-7.09%-2.58%

Financials

2026 *2027 *
Net sales 19.21B 16.8B 15.5B 14.24B 26.99B 1,849B 27.45B 185B 72.59B 904B 72.15B 70.57B 3,114B 19.73B 17.25B 15.91B 14.62B 27.71B 1,898B 28.18B 190B 74.52B 928B 74.08B 72.45B 3,197B
Net income 1.12B 983M 907M 834M 1.58B 108B 1.61B 10.83B 4.25B 52.89B 4.22B 4.13B 182B 1.45B 1.27B 1.17B 1.07B 2.04B 139B 2.07B 13.95B 5.48B 68.16B 5.44B 5.32B 235B
Net Debt 16.51B 14.44B 13.32B 12.24B 23.2B 1,589B 23.6B 159B 62.39B 777B 62.02B 60.66B 2,677B 13.96B 12.2B 11.26B 10.35B 19.61B 1,343B 19.94B 134B 52.73B 656B 52.42B 51.27B 2,263B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
15/07/26 US$154.88 +2.81% 1,992,843
14/07/26 US$150.65 -2.07% 1,908,103
13/07/26 US$153.83 +1.24% 1,403,825
10/07/26 US$151.94 +0.72% 1,048,174
09/07/26 US$150.85 +0.19% 1,788,623
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
154.88USD
Average target price
179.36USD
Spread / Average Target
+15.81%

Quarterly revenue - Rate of surprise